clofarabine


( Last Updated : September 17, 2021)
Generic Name:
clofarabine
Project Status:
Not filed
Therapeutic Area:
Acute lymphoblastic leukemia
Manufacturer:
sanofi-aventis Canada Inc.
Brand Name:
Clolar
Project Line:
Reimbursement Review
Project Number:
N/A

Details


Submission Type:
Non-submission
Indications:
For the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens.
Recommendation Type:
CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer